| Special Care Clinic | |
|
25815 Barton Rd Loma Linda CA 92354-3893 | |
| (909) 478-1100 | |
| Not Available |
| Full Name | Special Care Clinic |
|---|---|
| Speciality | Internal Medicine |
| Location | 25815 Barton Rd, Loma Linda, California |
| Authorized Official Name and Position | Michael Awad (ADMINISTRATOR) |
| Authorized Official Contact | 9095763310 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Special Care Clinic 1086 Rancho Valencia Dr Riverside CA 92508-8727 Ph: (951) 789-6339 | Special Care Clinic 25815 Barton Rd Loma Linda CA 92354-3893 Ph: (909) 478-1100 |
| NPI Number | 1699275644 |
|---|---|
| Provider Enumeration Date | 02/16/2018 |
| Last Update Date | 03/08/2018 |
| Medicare PECOS PAC ID | 9133479595 |
|---|---|
| Medicare Enrollment ID | O20180905002009 |
News Archive
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
In an editorial appearing in the October 25 issue of The New England Journal of Medicine, medical oncologists at Johns Hopkins and Brigham and Women's hospitals provide a four-point plan for integrating palliative care discussions throughout the treatment of patients with terminal illnesses.
Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699275644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 261QP2300X | Clinic/center - Primary Care | A55643 (California) | Secondary |
| Provider Name | Sami S Soliman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982795498 PECOS PAC ID: 8820082118 Enrollment ID: I20040409000643 |
News Archive
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
In an editorial appearing in the October 25 issue of The New England Journal of Medicine, medical oncologists at Johns Hopkins and Brigham and Women's hospitals provide a four-point plan for integrating palliative care discussions throughout the treatment of patients with terminal illnesses.
Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data.
› Verified 1 days ago
News Archive
Patients who had access to GP surgeries with longer opening times in evenings and at weekend visited accident and emergence departments far fewer times than those who did not have similar access to primary care.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
In an editorial appearing in the October 25 issue of The New England Journal of Medicine, medical oncologists at Johns Hopkins and Brigham and Women's hospitals provide a four-point plan for integrating palliative care discussions throughout the treatment of patients with terminal illnesses.
Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data.
› Verified 1 days ago
Loma Linda Inland Consortium For Healthcare Education Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25455 Barton Rd, Suite 209-b, Loma Linda, CA 92354 Phone: 909-558-6688 | |
Loma Linda University Physicians Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11375 Anderson St, Loma Linda, CA 92354 Phone: 909-558-2624 Fax: 909-558-3905 | |
Mazna Ahmad Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11374 Mountain View Ave, Suite A, Loma Linda, CA 92354 Phone: 909-478-0078 | |
Tahseen Shareef Md, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 11374 Mountain View Ave Ste A1, Loma Linda, CA 92354 Phone: 909-203-3825 Fax: 909-799-3888 | |
Cajon Medical Group Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11306 Mountain View Ave Ste C, Loma Linda, CA 92354 Phone: 909-735-2446 | |
Faculty Physicians And Surgeons Of Llusm Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St, Suite 3400, Loma Linda, CA 92354 Phone: 909-558-2870 |